Heart failure hope? major trial tests Selenium's power

NCT ID NCT07543562

Recruiting now Disease control Sponsor: Skane University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether taking a daily selenium supplement (200 micrograms) can reduce hospitalizations and heart-related deaths in people with heart failure. Selenium is a nutrient important for heart health, and low levels are common in Northern Europe. The trial will include over 4,300 adults in Sweden and Norway who are already receiving standard heart failure care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE FUNCTIONING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diastolic heart failure heart failure systolic heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE FUNCTIONING HEART FAILURE HEART FAILURE AND MILDLY REDUCED EJECTION FRACTION HEART FAILURE AND PRESERVED EJECTION FRACTION HEART FAILURE AND REDUCED EJECTION FRACTION SELENIUM SELENIUM SUPPLEMENTATION

Contacts and locations

Locations

Akademiska University hospital
RECRUITING

Uppsala, Sweden
Karolinska University Hospital
RECRUITING

Stockholm, Sweden
Linköping University Hospital
RECRUITING

Linköping, Sweden
Norrlands university Hospital
RECRUITING

Umeå, Sweden
Oslo University Hospital
RECRUITING

Oslo, Norway
Ryhov Hospital
RECRUITING

Jönköping, Sweden
Sahlgrenska
RECRUITING

Gothenburg, Sweden
Sahlgrenska University Hospital Östra
RECRUITING

Gothenburg, Sweden
Skånes University Hospital
RECRUITING

Malmö, Skåne County, Sweden
Skånes University Hospital
RECRUITING

Lund, Sweden
Örebro University Hospital
RECRUITING

Örebro, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.